ArticleMolecular oncology2017

Triplet therapy with afatinib, cetuximab, and bevacizumab induces deep remission in lung cancer cells harboring EGFR T790M in vivo.

Kenichiro Kudo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.